check_circleStudy Completed
Diagnostic Imaging
Bayer Identifier:
15515
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Observational study of Ultravist in patients requiring CECT
Trial purpose
It is a prospective, non-interventional, multi-center study. The primary objective of this study is to evaluate the image quality of Ultravist in patients requiring contrast-enhanced CT considering the routine use in patient population's, region's indication.
Key Participants Requirements
Sex
BothAge
0 - N/ATrial summary
Enrollment Goal
11660Trial Dates
September 2011 - November 2013Phase
N/ACould I Receive a placebo
NoProducts
Ultravist (Iopromide, BAY86-4877)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many locations, China |
Primary Outcome
- Image quality evaluated by calculated CNR (Contrast to Noise Ratio)date_rangeTime Frame:1 dayenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Image quality evaluated by calculated SNR (Signal Noise Ratio)date_rangeTime Frame:1 dayenhanced_encryptionNoSafety Issue:
- Descriptive analysis of contrast medial injection protocoldate_rangeTime Frame:1 dayenhanced_encryptionNoSafety Issue:
- Radiation dose (CTDIvol)date_rangeTime Frame:1 dayenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A